Patent Assignment
Reel/Frame 061179/0001
Security Interest
Recorded: 2022-08-16
Pages: 52
Assignor
RADIUS HEALTH, INC.
Executed: 2022-08-15
Assignee
WILMINGTON TRUST, NATIONAL ASSOCIATION
50 SOUTH SIXTH STREET, SUITE 1290, MINNEAPOLIS, MINNESOTA, 55402
Covered Properties
(60)
Method of Treating Cancer Using Selective Estrogen Receptor Modulators
Application:
16/549,828 →
Publication:
US US20200009084A1
Method of Treating Cancer Using Selective Estrogen Receptor Modulators
Application:
16/721,329 →
Publication:
US US20200121621A1
Method of Treating Cancer Using Selective Estrogen Receptor Modulators
Application:
16/986,492 →
Publication:
US US20200368184A1
Method of Treating Cancer Using Selective Estrogen Receptor Modulators
Methods for Treating Cancer
Methods for Treating Cancer
Treating Y537S Mutant Breast Cancer with RAD1901 and mTOR inhibitor
Polymorphic Forms of RAD1901-2HCL
Polymorphic Forms of RAD1901-2HCL
Methods For Treating Ovarian Cancer
Application:
16/336,358 →
Publication:
US US20200009085A1
Elacestrant in Combination with Abemaciclib in Women with Breast Cancer
Application:
17/298,198 →
Publication:
US US20220117963A1
Methods for Treating Cancer Resistant to CDK4/6 Inhibitors
Application:
17/299,948 →
Publication:
US US20210330612A1
Methods for Treating Cancer in Models Harboring ESR1 Mutations
Application:
17/299,361 →
Publication:
US US20220016052A1
Processes and Compounds
Estrogen Receptor-Modulating Compounds
Estrogen Receptor-Modulating Compounds
Stable Cannabinoid Formulations
Application:
17/367,876 →
Publication:
US US20210330797A1
Stable Cannabinoid Formulations
Stable Cannabinoid Formulations
Application:
15/166,476 →
Publication:
US US20160271252A1
Stable Cannabinoid Formulations
Application:
15/253,010 →
Publication:
US US20160367496A1
Stable Cannabinoid Formulations
Stable Cannabinoid Formulations
Stable Cannabinoid Formulations
Application:
17/519,844 →
Publication:
US US20220125932A1
Stable Cannabinoid Formulations
Application:
17/519,916 →
Publication:
US US20220054450A1
Stable Cannabinoid Formulations
Application:
17/559,155 →
Publication:
US US20220184215A1
Stable Cannabinoid Formulations
Application:
17/675,805 →
Publication:
US US20220280446A1
METHOD OF DRUG DELIVERY FOR PTH, PTHrP AND RELATED PEPTIDES
Application:
17/008,603 →
Publication:
US US20210052705A1
Method of Treating Osteoporosis Comprising Administration of Pthrp Analog
Patent:
49,444 →
Application:
17/133,968 →
Methods of Stimulating Bone Growth with Abaloparatide and Denosumab
Application:
17/871,180 →
Publication:
US US20230330191A1
USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK
Application:
17/471,543 →
Publication:
US US20220125887A1
Formulations of Pthrp Analogues, Transdermal Patches Thereof, and Uses Thereof
Application:
15/948,953 →
Publication:
US US20190091138A1
Formulations of Abaloparatide, Transdermal Patches Thereof, and Uses Thereof
Application:
17/209,777 →
Publication:
US US20210369816A1
Abaloparatide Formulations and Methods of Testing, Storing, Modifying, and Using Same
Methods for Detecting Neutralizing Antibodies to Parathyroid Hormone (Pth) and Parathyroid Hormone-Related Peptide (Pthrp) Analog
Transdermal System for the Delivery of Abaloparatide and Method of Use for Treating Osteoporosis
Application:
17/395,516 →
Publication:
US US20210379162A1
Methods of Improving Spinal Fusion with Abaloparatide
Process of Making Abaloparatide
Application:
63/344,375 →
Treatment and Prevention of Osteoporosis in High Body Mass Index Individuals
Application:
17/824,256 →
Publication:
US US20220378881A1
Treatment and Prevention of Osteoporosis in High Body Mass Index Individuals
Application:
63/192,935 →
Selective Estrogen Receptor Modulator
Selective Estrogen Receptor Modulator
Selective Estrogen Receptor Modulator
Method of Treating Cancer Using Selective Estrogen Receptor Modulators
Method of Treating Cancer Using Selective Estrogen Receptor Modulators
Method of Treating Cancer Using Selective Estrogen Receptor Modulators
Therapeutic Regimens
Treatment of vasomotor symptoms with selective estrogen receptor modulators
Polymorphic Forms of RAD1901-2HCL
Polymorphic Forms of RAD1901-2HCL
Polymorphic Forms of RAD1901-2HCL
Selective Androgen Receptor Modulators
Selective Androgen Receptor Modulators
Stable Cannabinoid Formulations
Method of Treating Osteoporosis Comprising Administration of Pthrp Analog
A Stable Composition Comprising a Pthrp Analogue
Method of Drug Delivery for Bone Anabolic Protein
Formulations of Abaloparatide, Transdermal Patches Thereof, and Uses Thereof
Formulations of Abaloparatide, Transdermal Patches Thereof, and Uses Thereof
Abaloparatide Formulations and Methods of Testing, Storing, Modifying, and Using Same
Methods for Detecting Neutralizing Antibodies to Parathyroid Hormone (Pth) and Parathyroid Hormone-Related Peptide (Pthrp) Analog
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 3, 2016
From: INSYS PHARMA, INC.
To: INSYS DEVELOPMENT COMPANY, INC.
Reel/Frame 037652/0049 →
Assignment of Assignor's Interest
Sep 27, 2016
From: VANGARA, KIRAN KUMAR; LI, HUAGUANG; YAN, NINGXIN; NGUYEN, HUNG Q
To: INSYS DEVELOPMENT COMPANY, INC.
Reel/Frame 039865/0701 →
Assignment of Assignor's Interest
Apr 11, 2019
From: HATTERSLEY, GARY
To: RADIUS PHARMACEUTICALS, INC.
Reel/Frame 048860/0425 →
Assignment of Assignor's Interest
Aug 30, 2019
From: WARDELL, SUZANNE E.; NELSON, ERIK R.; MCDONNELL, DONALD P.
To: DUKE UNIVERSITY
Reel/Frame 050226/0625 →
Assignment of Assignor's Interest
Oct 24, 2019
From: HATTERSLEY, GARY
To: RADIUS PHARMACEUTICALS, INC.
Reel/Frame 050816/0911 →
Assignment of Assignor's Interest
Dec 2, 2019
From: INSYS THERAPEUTICS, INC; INSYS PHARMA, INC.; INSYS DEVELOPMENT COMPANY, INC.
To: FRESH CUT DEVELOPMENT, LLC
Reel/Frame 051151/0685 →
Assignment of Assignor's Interest
Dec 2, 2019
From: FRESH CUT DEVELOPMENT, LLC
To: BENUVIA THERAPEUTICS INC.
Reel/Frame 051151/0852 →
Assignment of Assignor's Interest
Dec 19, 2019
From: BENUVIA THERAPEUTICS INC.
To: FRESH CUT DEVELOPMENT, LLC
Reel/Frame 051381/0283 →
Assignment of Assignor's Interest
Dec 26, 2019
From: WARDELL, SUZANNE E.; NELSON, ERIK R.; MCDONNELL, DONALD P.
To: DUKE UNIVERSITY
Reel/Frame 051371/0147 →
Security Interest (Term)
Jan 15, 2020
From: RADIUS HEALTH, INC.; RADIUS PHARMACEUTICALS, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 051618/0200 →
Security Interest (Revolving)
Jan 15, 2020
From: RADIUS HEALTH, INC.; RADIUS PHARMACEUTICALS, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 051618/0758 →
Assignment of Intellectual Property Security Agreement
Jul 6, 2020
From: MIDCAP FINANCIAL TRUST
To: MIDCAP FUNDING IV TRUST
Reel/Frame 053131/0465 →
Release of Security Interest
Jul 27, 2020
From: MIDCAP FINANCIAL TRUST; MIDCAP FUNDING IV TRUST
To: RADIUS PHARMACEUTICALS, INC.; RADIUS HEALTH, INC.
Reel/Frame 053315/0231 →
Assignment of Assignor's Interest
Aug 6, 2020
From: WARDELL, SUZANNE E.; NELSON, ERIK R.; MCDONNELL, DONALD P.
To: DUKE UNIVERSITY
Reel/Frame 053419/0630 →
Assignment of Assignor's Interest
Aug 13, 2020
From: MILLER, CHRIS
To: RADIUS PHARMACEUTICALS, INC.
Reel/Frame 053490/0987 →
Assignment of Assignor's Interest
Mar 16, 2021
From: HATTERSLEY, GARY; GARNER, FIONA
To: RADIUS PHARMACEUTICALS, INC.
Reel/Frame 055608/0547 →
Security Agreement Supplement (Term)
Mar 17, 2021
From: RADIUS HEALTH, INC.; RADIUS PHARMACEUTICALS, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 055632/0653 →
Reaffirmation, Joinder & Amendment to Security Agreement (Term)
Mar 17, 2021
From: RADIUS HEALTH, INC.; RADIUS PHARMACEUTICALS, INC.; RADIUS HEALTH VENTURES, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 055632/0017 →
Reaffirmation, Joinder & Amendment to Security Agreement (Revolving)
Mar 17, 2021
From: RADIUS HEALTH, INC.; RADIUS PHARMACEUTICALS, INC.; RADIUS HEALTH VENTURES, INC.
To: MIDCAP FUNDING IV TRUST, AS AGENT
Reel/Frame 055632/0316 →
Security Agreement Supplement (Revolving)
Mar 17, 2021
From: RADIUS HEALTH, INC.; RADIUS PHARMACEUTICALS, INC.
To: MIDCAP FUNDING IV TRUST, AS AGENT
Reel/Frame 055632/0634 →
Assignment of Assignor's Interest
Apr 13, 2021
From: FRESH CUT DEVELOPMENT, LLC
To: RADIUS PHARMACEUTICALS, INC.
Reel/Frame 055903/0587 →
Assignment of Assignor's Interest
May 17, 2021
From: FRESH CUT DEVELOPMENT, LLC
To: RADIUS PHARMACEUTICALS, INC.
Reel/Frame 056262/0235 →
Assignment of Assignor's Interest
Jun 3, 2021
From: CRUSKIE, MICHAEL PAUL; BOLGER, JOSHUA KYLE; MCKENZIE, JONATHAN BLAKE; SHETH, PRATIK
To: RADIUS PHARMACEUTICALS, INC.
Reel/Frame 056424/0815 →
Change of Address
Jun 23, 2021
From: RADIUS PHARMACEUTICALS, INC.
To: RADIUS PHARMACEUTICALS, INC.
Reel/Frame 056650/0043 →
Assignment of Assignor's Interest
Jul 6, 2021
From: FRESH CUT DEVELOPMENT, LLC
To: RADIUS PHARMACEUTICALS, INC.
Reel/Frame 056766/0125 →